Stefansson is an International Member of the US National Academy of Sciences, he is a member of the European Molecularbiology Organization (EMBO) and he is the recipient of the American Society of Human Genetics (ASHG) William Allan Award, the European Society of Human Genetics Award, the Anders Jahre Award, the Federation of European Biomedical Societies Sir Hans Krebs Medal, the European Heart Association Gold Medal, the World Glaucoma Association Award, the American Alzheimer’s Association’s Inge Grundke-Iqbal Award, the Wallace H. So Stefánsson left academic medicine and returned to Reykjavík where he founded deCODE Genetics with Jeffrey Gulcher. An interview with Kari Stefansson, founder and CEO of deCODE Genetics in Reykjavik, Iceland. Stefansson was a professor of neurology, neuropathology and neuroscience at Harvard Medical School and before that he held the same positions at the University of Chicago, Pritzker School of Medicine.ĭr. 10 deCODE Genetics/Amgen, Reykjavik, Iceland. 9 Department of Immunology, Landspitali University Hospital, Reykjavik, Iceland. 8 National Institute of Hearing and Speech in Iceland, Reykjavik, Iceland. He pioneered the use of population genetics in the. Kari Stefansson The genetic basis of the human vocal system is largely unknown, as are the sequence variants that give rise to individual differences in voice and speech. deCODE genetics and colleagues from the Max Planck Institute and universities in Denmark and Iceland today publish in Nature the first study to use whole-genome sequence data from across a population to shed light on the present-day legacy of interbreeding between modern and archaic humans more than 50,000 years ago. 7 Division of Cardiology, Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland. His work has been published in over 700 scientific papers and includes discoveries of variants in the sequence of the germline genome that affect the risk of a large number of common diseases (ca. Kari Stefansson MD, PhD is a founder and CEO of the Icelandic biotechnology company deCODE genetics. The population approach he advanced in Iceland has served as a model for large scale genome projects around the world. He pioneered the use of population genetics in the study of human diversity, how human diversity is generated through diversity in the sequence of the human genome and how diversity in the sequence of the genome is generated through de novo mutations, recombinations and gene conversions. Outspoken doctor Kári Stefánsson founded Iceland’s deCODE Genetics to use its citizens’ genealogy in the hunt for human disease genes. ![]() ![]() ![]() Kari Stefansson MD, PhD is a founder and CEO of the Icelandic biotechnology company deCODE genetics.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |